Occlusions of the M2 segment of the middle cerebral artery may cause significant clinical effects, especially when occurring in the dominant cerebral hemisphere, yet endovascular treatment of these lesions remains controversial. OBJECTIVE: To examine the safety and efficacy of endovascular treatment of M2 occlusions at our institution. METHODS: We retrospectively examined radiographic and clinical data of 53 patients presenting with M2 occlusions to our institution. RESULTS: Successful recanalization (Thrombolysis in Cerebral Infarction grade 2b or 3) was achieved in 40 patients (76.9%). No symptomatic intracranial hemorrhage occurred. The mean National Institutes of Health Stroke Scale score at discharge was 6.4 (median, 5.5). In the 38 patients who had follow-up after discharge, the mean follow-up duration was 11.1 months (range, 0.5-36.5 months) and mean National Institutes of Health Stroke Scale score was 3.5 (median, 1).
W ith this year's publication of 5 randomized, controlled trials, endovascular therapy (in combination with intravenous thrombolysis) has been demonstrated to provide clear benefit for patients with acute proximal (ie, internal carotid artery terminus and M1 segment of the middle cerebral artery), anterior circulation, intracranial arterial occlusion. [1] [2] [3] [4] [5] These studies showed that endovascular therapy provided reliable recanalization and clear functional neurological benefit without increasing the risk of hemorrhagic complications or mortality. Consequently, intravenous tissuetype plasminogen activator (t-PA) plus endovascular therapy is becoming the first-line treatment for these occlusive lesions.
Although affecting far less territory, M2 occlusions still may result in significant clinical deficit and functional impairment, particularly when they occur in the dominant hemisphere. The necessity of M2 recanalization was questioned by a subgroup analysis of the Interventional Management of Stroke (IMS) II trial, which demonstrated low rates of recanalization (arterial occlusive lesion grade 3 recanalization, 43.5%) but high rates of good clinical outcome (modified Rankin scale [mRS] score 0-2, 69.5%). 6 Similarly, retrospective analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI trials demonstrated that even though high rates of M2 recanalization were possible (Thrombolysis in Myocardial Infarction grade II/III recanalization in 71.4%), good clinical outcome remained marginal (mRS score 0-2 in 40.7%). 7 However, more recently, positive correlations have been shown between reperfusion and outcome in patients with M2 occlusions.
The role of endovascular therapy in the treatment of M2 occlusions remains unclear.
Although more recent data suggest improvement in outcome with recanalization, the most effective and safest means of achieving this is ill defined. Here, we evaluate the radiographic and clinical outcomes of patients with M2 occlusions treated by endovascular techniques at our institution.
METHODS

Patients, Study Design, and Setting
After receiving institutional board approval, we retrospectively identified patients who underwent acute endovascular stroke intervention at our institution between January 2010 and May 2015 by querying Current Procedural Terminology codes 37184, 37185, and 37186. Our query resulted in the identification of 217 patients. Radiographic and angiographic (digital subtraction, computed tomographic [CT], magnetic resonance) review was used to identify patients with M2 occlusions. Only those with angiographic evidence of M2 occlusion were included in subsequent analysis. We defined the M2 segment as beginning at the limen insulae, where the middle cerebral artery makes a superior turn, and ending at the apex of the circular sulcus. 8 Baseline demographic and clinical data (eg, age, sex, functional status, medical history, National Institutes of Health Stroke Scale [NIHSS] score, and radiographic information) were obtained by review of electronic medical records. As reported previously, 9 we routinely evaluate patients presenting with stroke symptoms using noncontrast head CT, CT angiography of the head and neck, and CT perfusion imaging (Figure 1 ). Patients with unfavorable perfusion profiles routinely are not deemed candidates for endovascular revascularization. At our institution, we apply a selection process that relies primarily on perfusion imaging, regardless of time of symptom onset. In this way, patients with favorable perfusion profiles are eligible for endovascular stroke intervention. With the use of these criteria, the decision to proceed with endovascular intervention routinely is made via a multidisciplinary evaluation by the endovascular neurosurgeon and stroke neurologist.
The endovascular technique of revascularization typically is left to the discretion of the treating endovascular neurosurgeon. Over the course of this analysis, several new techniques were developed and incorporated into practice as they became available. Techniques used in this study included intra-arterial thrombolysis, balloon angioplasty, mechanical disruption with wire manipulation, 10 Merci retriever (Stryker Neurovascular, Kalamazoo, Michigan) thrombectomy, 11 Penumbra (Penumbra Inc, Alameda, California) aspiration with separator, 12 direct aspiration first pass technique (ADAPT), 13 and retrievable-stent thrombectomy. 14 
Data Sources/Measurement
We evaluated radiographic and clinical outcomes. The degree of recanalization was graded according to the Thrombolysis in Cerebral Infarction (TICI) score on the last angiographic run (successful recanalization, TICI grade 2b/3). Postprocedural hemorrhage was determined by review of head CT studies performed within the 30-day postprocedural time frame. Any hemorrhage was categorized according to European-Australasian Cooperative Acute Stroke Study (ECASS) II criteria. 15 Any untoward clinical events attributable to the procedure were noted. Clinical outcome was assessed according to NIHSS scores at hospital discharge and last clinical follow-up evaluation. Patients lost to follow-up after their discharge were included in our statistical analysis of clinical outcome only at discharge and not at last clinical follow-up. Computed tomographic perfusion imaging of a representative patient with a right M2 occlusion. There is increased time to peak in the vascular region supplied by the occluded artery (A). The cerebral blood volume is increased, suggesting viable but at-risk tissue (B). In patients in whom completed infarction has occurred, the cerebral blood volume is decreased. Given the extent of potentially salvageable penumbra seen in these images, this perfusion profile is favorable for recanalization. Color version available online only.
Statistical Methods
Wilcoxon-Mann-Whitney and Kruskal-Wallis tests were used to determine statistically significant differences, depending on whether the tested variables had 2 or . 2 possible outcomes, respectively. Spearman correlation was used to test significant correlations. A value of P , .05 was considered statistically significant.
RESULTS
Demographics and Clinical Data
We identified 53 patients who presented with acute M2 occlusion and underwent endovascular therapy at our institution ( Figure 2 ). Baseline demographic and clinical information is presented in Table 1 . In 1 patient, the procedure was aborted as a result of extreme agitation compromising patient safety. Therefore, this case was not included in our analysis.
Among the 52 study patients, the mean NIHSS score at presentation was 15 (SD, 4.69; median, 16). The TICI score at initial evaluation was 0 in 43 patients (82.7%), 1 in 8 patients (15.1%), and 2a in 1 patient (1.9%). M2 occlusions occurred on the left side in 37 patients (71.1%). Twenty patients (38.5%) received intravenous t-PA before undergoing endovascular intervention. Retrievable stents were used in 30 patients (57.7%), whereas ADAPT was used in 5 (9.6%), and Penumbra aspiration with separator was used in 6 (11.5%). Additional baseline and clinical data are presented in Table 1 .
The mean hospital length of stay was 16.0 days (median, 8.0 days). Mean NIHSS score at discharge was 6.4 (median, 5.5; Table 2 ). In the 38 patients who had follow-up after discharge, the mean follow-up duration was 11.1 months (range, 0.5-36.5 months), and the mean NIHSS score was 3.5 (median, 1).
Outcome Data and Analysis
Successful recanalization (TICI grade 2b or 3) was achieved in 40 of 52 patients (76.9%): TICI grade 2b in 22 patients (42.3%) and TICI grade 3 in 18 (34.6%). The degree of reperfusion had a statistically significant effect on the NIHSS score at discharge ( Table 3 ). The mean NIHSS score at discharge in patients with successful recanalization was 5.4 (median, 2.0).
We experienced 2 procedure-related complications (3.8%): 1 patient experienced subarachnoid hemorrhage after angioplasty for an occlusion refractory to aspiration, and 1 patient suffered vessel perforation during attempted wire manipulation. Eleven patients (21.2%) experienced postprocedural intracranial hemorrhage ; Table 4 ). However, none of these hemorrhages were symptomatic. Three patients (5.7%) died during their admission, but none of these deaths were a result of procedure-related complications.
We found left-sided occlusion and lack of preprocedural functional independence to be statistically significant predictors of poorer NIHSS score at discharge ( Table 2 ). The year of treatment was also found to have a statistically significant impact on NIHSS score at discharge, with a general trend of lower scores occurring in patients treated later during our study period. Only left-sided occlusion remained a statistically significant predictor of poorer NIHSS at last follow-up (Table 2 ). Presenting NIHSS also was found to correlate significantly with NIHSS at discharge and at the last follow-up.
DISCUSSION Interpretation and Context of Results
Clinical management paradigms for M2 occlusions remain unclear. On one hand, M2 occlusions may result in significant When evaluating a patient for possible endovascular therapy, practitioners are faced with the question of whether recanalization is necessary for good neurological outcome. The answer to this question may depend on many factors, including location of the occlusion. Rahme et al 16 recently performed a pooled analysis of patients with M2 occlusion in the Prolyse in Acute Cerebral Thromboembolism (PROACT) II trial, 17 IMS, 18 and IMS II 19 to evaluate the effects of early reperfusion on functional outcome. They found no difference in functional independence (mRS score 0-2) in patients who experienced early reperfusion (TICI grade 2-3) compared with those who did not (TICI 0-1). They also noted a statistically insignificant trend toward a higher incidence of symptomatic ICH in patients experiencing early reperfusion (17.4% vs 0% in the TICI 0-1 group; P = .11). Noting that patients with M2 occlusions generally had better outcomes, even without treatment, than those with more proximal occlusions (ie, .50% of patients achieved functional independence at 3 months), those authors imply that endovascular efforts for early reperfusion of M2 occlusions should not be pursued. Although thoroughly conducted, this pooled analysis 16 should be interpreted with caution and in the context of present-day endovascular stroke therapy. In PROACT II, 17 IMS, 18 and IMS II, 19 endovascular therapy consisted of local intra-arterial administration of thrombolytics. Although this technique remains in the endovascular armamentarium, it typically is not the first-line therapy in contemporary endovascular stroke treatment. In the present study, we used intra-arterial t-PA in only 1 patient with a right-sided M2 occlusion. Although in this patient we observed TICI 3 reperfusion and an improvement in NIHSS score from 14 to 1, the small number of patients treated with this technique limits its comparison with other techniques in our study.
In contrast, Flores et al 20 recently described a more current approach to treating 65 patients with M2 occlusions, using stentrievers in 56 patients (86.2%). In their study, 53.8% received intravenous t-PA before endovascular intervention. Good recanalization (TICI grade 2b/3) was achieved in 78.5%, and these patients had more dramatic improvement and smaller infarct volumes than those in whom recanalization was not achieved. Good recanalization was an independent predictor of good outcome (mRS score 0-2), which was observed in 60%. Similar to the results of our study, presenting NIHSS score also correlated significantly with outcome. Those authors included all patients in their statistical analysis, so the specific effects of stentriever thrombectomy could not be isolated in this study. However, in contrast to the aforementioned pooled analysis, this study suggests that rapid recanalization with contemporary endovascular techniques can significantly affect neurological outcome.
Most recently, Dorn et al 21 described their experience with stent-retriever-based thrombectomy, including in 15 patients with M2 occlusions. In all of these patients, a 4 · 20-mm Solitaire FR (Covidien/ev3 Inc, Irvine, California) was used. They reported successful recanalization (TICI grade 2b/3) in 93.3% and favorable functional outcome (mRS score 0-2) at 90 days in 60%. One symptomatic ICH was observed; however, 14 of 15 patients (93.3%) experienced clinically insignificant hemorrhagic transformation. Although the number of patients with M2 occlusions was small, these results compare favorably with those reported in the present study.
We identified 52 patients with M2 occlusions treated over a period of 4.4 years with a variety of techniques commensurate with the time of treatment. We observed a general trend in improved outcomes with patients treated later in our study. However, to our surprise, this did not appear to be a function of the This patient experienced postprocedural ICH as a result of vessel perforation and is also counted in the postprocedural ICH group. c Postprocedural ICH is classified according to European-Australasian Cooperative Acute Stroke Study (ECASS) II criteria.
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specific endovascular technique used. The lack of statistical significance according to endovascular technique may be a result of the wide variety of techniques used, thereby diluting the number of patients treated with each technique. The observation of improved outcome when patients were treated later in the study may also be a result of increasing experience (ie, the presence of a learning curve) with endovascular stroke treatment and mechanical thrombectomy.
Thirty patients (57.7%) underwent mechanical thrombectomy of their M2 occlusion with a retrievable stent or stent retriever (illustrative case in Figure 3 ). In 23 of these patients (44.2%), the stent retriever was used with concomitant aspiration through a dedicated aspiration catheter. The use of an aspiration catheter did not result in any significant clinical effect. The NIHSS scores at discharge were 5.2 and 6.0 for those undergoing thrombectomy with stentriever plus aspiration and stentriever alone, respectively. For this reason, we considered these patients as 1 group.
Limitations and Generalizability
Our study is a retrospective analysis of patients treated at a single institution. Therefore, it is subject to the limitations and biases inherent to this type of study. Our institutional approach to the triage of patients presenting with acute ischemic stroke has been described previously 9 and may have influenced our results. In this way, we did not triage patients according to time of symptom onset, and patients with favorable perfusion profiles were eligible for endovascular stroke treatment, regardless of time from symptom onset. The effects of this triage paradigm on outcome cannot be compared with other techniques. However, CT perfusion profile has previously been demonstrated to be an effective means of patient selection. 22, 23 We believe that the use of perfusion imaging is critical and continue to advocate for its use in the evaluation of these patients. In 14 patients, we did not have a clinical evaluation after their discharge from the hospital. The absence of this data may have affected the analysis and conclusions surrounding outcome at last follow-up because these patients were not included in this analysis.
An additional limitation to our study is that clinical outcome was assessed by NIHSS score at discharge and at outpatient followup, when available, rather than by functional scales (eg, Barthel Index or mRS score). However, these scales have been shown to correlate favorably. 24 We observed clinically significant improvements in our cohort of patients treated with endovascular therapy. Although in this study we did not compare these effects with those seen in patients treated with medical therapy alone, these clinical improvements are greater than those in medically treated patients reported in the literature (25%-30% achieving an mRS score of 0-2). 16, 25 In our study, on average, the NIHSS score had improved by 8.4 points at the time of hospital discharge (mean NIHSS score at discharge, 6.4). In those patients with additional clinical follow-up, the NIHSS score had improved to a mean of 3.5, an improvement of a mean of 11.2 points. These data demonstrate that clinically significant functional improvements occurred in most patients, with NIHSS scores suggesting nondebilitating residual deficits.
Our study suggests that endovascular treatment of M2 occlusions is safe. Although postprocedural hemorrhage may occur (in our study, 21.2% experienced postprocedural ICH), these hemorrhages are rarely symptomatic (eg, in our study, all were asymptomatic). As previously discussed, a similar phenomenon was observed in the study by Dorn et al, 21 in which ICH was observed in 93% of patients but was symptomatic in only 1 patient.
Additional large-scale, randomized, controlled, prospective evaluations are needed to further assess the benefits of endovascular treatments of M2 occlusions and to directly compare them with medical treatments. However, in our single-institution experience, endovascular recanalization of M2 occlusions appears to be associated with a reliable rate of recanalization. In contrast to previous reports, this recanalization correlates significantly with clinical outcome.
CONCLUSION
Although generally not considered large-vessel occlusion, M2 occlusions can manifest with significant clinical deficits. Endovascular treatment of M2 occlusions is associated with considerable improvement in NIHSS score. Although postprocedural ICH may occur, it is rarely symptomatic. Additional prospective, randomized, controlled studies are needed to further elucidate the clinical benefit of endovascular revascularization of M2 occlusions. 
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